SPHK2 and colorectal carcinoma: In that sense, specific inhibition of SphK2 with ABC294640 in colorectal cancer (CRC) cells reduced S1P and increases ceramide levels, thus inhibiting CRC cells and xenografts growth in vitro and in vivo, respectively (50).